FIELD: pharmacology.
SUBSTANCE: method for antibody production, a method for production of a pharmaceutical preparation containing an antibody obtained by this method, a nucleic acid molecule, application of a vector containing such nucleic acid molecule, and application of a cell where the said nucleic acid molecule or vector is artificially introduced in the method for antibody production. This method for antibody production involves culturing a cell that expresses an antibody-enhancing sequence (APES) that has been artificially inserted into a cell and into which an exogenous DNA encoding the desired antibody was introduced to produce the desired antibody, and wherein APES is a nucleic acid molecule containing a nucleotide sequence that can bind to DNA or mRNA of NfkBia gene derived from a human, mouse, rat, or hamster by base pairing, and can suppress expression of the NfkBia gene.
EFFECT: invention allows production of an antibody at a high level with suppression of NfkBia expression.
16 cl, 29 dwg, 8 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PRODUCING CELL CAPABLE TO PRODUCE HETEROPROTEINS WITH HIGH YIELD | 2008 |
|
RU2486245C2 |
| METHOD OF PREPARING HETEROLOGOUS PROTEINS | 2008 |
|
RU2487168C2 |
| THERAPEUTIC COMPOUNDS FOR TREATING HUNTINGTON'S DISEASE | 2015 |
|
RU2711147C2 |
| NUCLEIC ACIDS MOLECULES THAT PROVIDE RESISTANCE TO BEETLE PESTS | 2011 |
|
RU2639549C2 |
| COMPOSITIONS, AGENTS, KITS AND TECHNIQUES FOR DIAGNOSING, MONITORING AND TREATING OBESITY AND/OR DIABETES | 2004 |
|
RU2420583C2 |
| NEW ISOFORMS OF VASCULAR ENDOTHELIAL CELL GROWTH INHIBITOR | 2002 |
|
RU2316591C2 |
| MTS GENE, MUTATIONS OF THIS GENE AND METHODS OF DIAGNOSIS OF MALIGNANT TUMORS USING MTS GENE SEQUENCE | 1995 |
|
RU2164419C2 |
| NEW MINIMUM UTR SEQUENCES | 2017 |
|
RU2759737C2 |
| CORYNEBACTERIUM GLUTAMICUM GENES ENCODING PROTEINS INVOLVED IN MEMBRANE SYNTHESIS AND MEMBRANE TRANSPORT | 2000 |
|
RU2312145C2 |
| TREATMENT OF HBV INFECTION | 2011 |
|
RU2620966C2 |
